Kore Private Wealth’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-250
Closed -$20K 822
2020
Q2
$20K Hold
250
﹤0.01% 649
2020
Q1
$3K Hold
250
﹤0.01% 885
2019
Q4
$1K Buy
+250
New +$1.08K ﹤0.01% 1001
2019
Q2
Sell
-250
Closed -$3K 608
2019
Q1
$3K Hold
250
﹤0.01% 828
2018
Q4
$9K Buy
+250
New +$9.69K ﹤0.01% 581

Other funds holding NVAX

Kore Private Wealth's NVAX Position: Q3 2020 in Review

Kore Private Wealth sold out of Novavax (NVAX) in Q3 2020, closing a stake of 250 shares — an estimated $20K sold.

Kore Private Wealth first reported a position in NVAX in Q4 2018 and held it in 5 quarters. The position peaked at $20K in Q2 2020. 311 funds tracked by Wall St. Rank hold NVAX as of Q3 2020.

  • Kore Private Wealth reported no remaining Novavax position as of Q3 2020 after selling out during the quarter.
  • Kore Private Wealth sold 250 Novavax shares in Q3 2020, an estimated $20K.
  • Kore Private Wealth first reported a position in Novavax in Q4 2018 and held it in 5 quarters.
  • Kore Private Wealth's Novavax position peaked at $20K in Q2 2020.
  • 311 funds tracked by Wall St. Rank held Novavax as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.